Immunogenicity and Safety of a Single Dose or Two Doses Given 28 Days Apart of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Subjects Aged 6 Months or Older in India
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007643/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The aim of the study was to generate immunogenicity and safety data in the whole population
to support registration of the Quadrivalent Influenza Vaccine (QIV) in India:
Primary objective:
- To describe in each age group the immune response induced by a single injection
(participants aged >9 years) or 2 injections (participants aged 6 months to 8 years) of
QIV.
Secondary objective:
- To describe in each age group the safety profile of QIV.
提供机构：
Vivli
创建时间：
2022-02-02
